Determination That RECTIV (Nitroglycerin) Ointment, 0.4%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

NoticeFDA-2026-P-4566-0004
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from the source system.

Title
Determination That RECTIV (Nitroglycerin) Ointment, 0.4%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Posted
Jun 26, 2026
Comment period
Jun 26, 2026 – ?
FR Doc
2026-12953
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.